Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights

Go back to Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights
(NASDAQ: NVCT) Delayed: 18.39 --0 (-0%)
Previous Close $18.39    52 Week High
Open $18.39    52 Week Low
Day High $18.39    P/E N/A 
Day Low $18.39    EPS
Volume 239